Imagine you have your lead RNA candidate for your therapeutic. You think your candidate is ready for scale-up and you start manufacturing with a GMP partner. However, after you manufacture, you find increased levels of double-stranded RNA (dsRNA) impurities or a sudden drop in potency. You cannot move forward with the manufactured RNA as-is, but the cost to fix it is costly. ...
Subscribe to Eclipsebio’s news feed.
Click on “Follow” and decide if you want to get news from Eclipsebio via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Eclipsebio comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Eclipsebio which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Eclipsebio | RNA Solutions